Cited by 456Treatment of Major DepressionPain Management and Placebo EffectAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database

Khan, Arif, Leventhal, Robyn M., Khan, Shirin R., Brown, Walter A.·2002·Journal of Clinical Psychopharmacology

DOI 10.1097/00004714-200202000-00007

Open this paper in CoChat — free account

Abstract

Some studies suggest that more severely ill patients with depression respond well to antidepressants and poorly to placebo, whereas those who are mildly ill respond equally well to antidepressants and placebo. This notion has implications for the design of clinical trials. To further assess and substantiate these putative predictors of antidepressant and placebo response, we assessed the Food and Drug Administration database of 45 phase II and III antidepressant clinical trials. The frequency of statistically significant differences between antidepressants and placebo was higher in the trials that included patients with more severe depression. In the antidepressant-treated groups, the magnitude of symptom reduction was significantly related to mean initial Hamilton Rating Scale for Depression (HAM-D) score; the higher the mean initial HAM-D score, the larger the change. With placebo treatment, however, the higher the mean initial HAM-D score, the smaller the change. Early discontinuation was more frequent among patients whose mean initial HAM-D scores were higher. These data may help inform the design of future antidepressant clinical trials.

Integrity signals

Registry

Crossref · 10.1097/00004714-200202000-00007

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
National Institute of Mental Health Treatment of Depression Collaborative Research Program: General Effectiveness of Treatments
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials
Khan, A., Warner, H. A., & Brown, W. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.311 · Cited by 475
Self-citation
Prediction of Tricyclic Antidepressant Response
Bielski, R. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770120083009 · Cited by 349
Predictors of Drug Response in Depression
Joyce, P. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010091014 · Cited by 279
Clinical pharmacology of imipramine and related antidepressant compounds.
KLERMAN, G. L., & Jo, C. (1967) · PubMed · Cited by 273
Which depressions respond to placebo?
Fairchild, C., Rush, A. J., Vasavada, N., Giles, D. E., & Khatami, M. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90109-5 · Cited by 106
Clinical features of depressed patients who do and do not improve with placebo
Brown, W. A., Johnson, M. F. K., & Chen, M.-G. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90002-k · Cited by 102
Self-citation
Neurophysiologic predictors of treatment response to fluoxetine in major depression
Cook, I. A., Leuchter, A. F., Witte, E. A., Abrams, M., Uijtdehaage, S. H. J., Stubbeman, W. F., Rosenberg-Thompson, S., & Anderson‐Hanley, C. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00010-4 · Cited by 70
Predictors of placebo response: a retrospective analysis.
Wilcox, C. S., Cohn, J. B., Rd, L., Heiser, J. F., Lucas, P. B., Morgan, D. L., & Defrancisco, D. F. (1992) · PubMed · Cited by 59

Show all 21 references

Research works printed but not linked: 6

Klerman, 1965, Pharmacol Rev, 17, 101
Morris, 1974, Arch Gen Psychiatry, 31, 33
Brown, 1988, Psychopharmacol Bull, 24, 14
Galinowski, 1991, Encephale, 17, 387
Peselow, 1989, Br J Psychiatry, 155, 667
Wilcox, 1992, Psychopharmacol Bull, 28, 157

Sorted by citations

Items 101–200 of 456

Developing a culturally sensitive group support intervention for depression among HIV infected and non-infected Ugandan adults: A qualitative study
Nakimuli‐Mpungu, E., Wamala, K., Okello, J., Alderman, S., Odokonyero, R. F., Musisi, S., & Mojtabai, R. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.042 · Cited by 66
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
Mallinckrodt, C. H., Zhang, L., Prucka, W. R., & Millen, B. A. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4282 · Cited by 64
A critical review of pharmacotherapy for major depressive disorder.
Dupuy, J. M., Ostacher, M. J., Huffman, J., Perlis, R. H., & Nierenberg, A. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000083 · Cited by 61
Fungus mediated biogenic synthesis and characterization of chitosan nanoparticles and its combine effect with Trichoderma asperellum against Fusarium oxysporum, Sclerotium rolfsii and Rhizoctonia solani
Boruah, S., & Dutta, P. (2020) · Indian Phytopathology · doi:10.1007/s42360-020-00289-w · Cited by 63
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients
Nemeroff, C. B., & Thase, M. E. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.009 · Cited by 62
Heterogeneity in the prognosis of major depression: From the common cold to a highly debilitating and recurrent illness
Lorenzo-Luaces, L. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000542 · Cited by 55
Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis
Weinmann, S., Becker, T. M., & Koesters, M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0975-9 · Cited by 61
Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials
Rabinowitz, J., Werbeloff, N., Mandel, F. S., Ménard, F., Marangell, L. B., & Kapur, S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.173906 · Cited by 59
The treatment of minor depression with St. John’s Wort or citalopram: Failure to show benefit over placebo
Rapaport, M. H., Nierenberg, A. A., Howland, R. H., Dording, C. M., Schettler, P. J., & Mischoulon, D. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.05.001 · Cited by 59
Folate Augmentation of Treatment – Evaluation for Depression (FolATED): randomised trial and economic evaluation
Bedson, E., Bell, D., Carr, D. F., Carter, B., Hughes, D. A., Jorgensen, A., Lewis, H., Lloyd, K. R., McCaddon, A., Moat, S. J., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18480 · Cited by 63
Spectrum and nosology: implications for DSM-V
Maser, J. D., & Patterson, T. F. (2002) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00022-9 · Cited by 59
Predicting the Outcome of Antidepressants and Psychotherapy for Depression: A Qualitative, Systematic Review
Van, H. L., Schoevers, R. A., & Dekker, J. (2008) · Harvard Review of Psychiatry · doi:10.1080/10673220802277938 · Cited by 57
Placebo, Prozac and PLoS: significant lessons for psychopharmacology
Horder, J., Matthews, P., & WALDMANN, R. J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110372544 · Cited by 57
Alzheimers Disease Drug Development in 2008 and Beyond: Problems and Opportunities
Becker, R. E., & Greig, N. H. (2008) · Current Alzheimer Research · doi:10.2174/156720508785132299 · Cited by 55
St. John's Wort Versus Placebo in Social Phobia
Kobak, K. A., Taylor, L. V. H., Warner, G., & Futterer, R. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150227.61501.00 · Cited by 55
Homeopathic Individualized Q‐Potencies versus Fluoxetine for Moderate to Severe Depression: Double‐Blind, Randomized Non‐Inferiority Trial
Adler, U. C., Paiva, N. M. P., César, A., Adler, M. S., Molina, A., Padula, A. E. M., & Calil, H. M. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep114 · Cited by 56
Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait
Al-Saffar, N., Deshmukh, A. A., Carter, P., & Adib, S. M. (2005) · International Journal of Pharmacy Practice · doi:10.1211/0022357056181 · Cited by 54
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.
Santen, G., Gomeni, R., Danhof, M., & Pasqua, O. D. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.11.004 · Cited by 59
Effect of Micronutrients on Behavior and Mood in Adults With ADHD: Evidence From an 8-Week Open Label Trial With Natural Extension
Rucklidge, J. J., Taylor, M. R., & Whitehead, K. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709356173 · Cited by 62
Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression
Möller, H. ‐., Bitter, I., Bobes, J., Fountoulakis, K. Ν., Höschl, C., & Kasper, S. F. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.08.002 · Cited by 53
Enriched rater training using Internet based technologies: A comparison to traditional rater training in a multi-site depression trial
Kobak, K. A., Engelhardt, N., & Lipsitz, J. D. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.012 · Cited by 52
Accurate pain reporting training diminishes the placebo response: Results from a randomised, double-blind, crossover trial
Treister, R., Lawal, O. D., Shecter, J. D., Khurana, N., Bothmer, J., Field, M. J., Harte, S. E., Kruger, G. H., & Katz, N. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197844 · Cited by 51
Detection and Management of Depressive Disorders in Primary Care in Spain
Aragonès, E., Piñol, J. L., Labad, A., Folch, S., & Mèlich, N. (2004) · The International Journal of Psychiatry in Medicine · doi:10.2190/n835-fdyx-2e2e-v8xm · Cited by 51
Influence of baseline severity on antidepressant efficacy for anxiety disorders: Meta-analysis and meta-regression
de Vries, Y. A., de Jonge, P., van den Heuvel, E., Turner, E. H., & Roest, A. M. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.173450 · Cited by 50
What Do Placebo and Nocebo Effects Have to Do With Health Equity? The Hidden Toll of Nocebo Effects on Racial and Ethnic Minority Patients in Clinical Care
Yetman, H. E., Cox, N., Adler, S. R., Hall, K. T., & Stone, V. E. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.788230 · Cited by 52
Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis
Chen, C., & Shan, W. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112595 · Cited by 53
Relationship Between Depression Severity Entry Criteria and Antidepressant Clinical Trial Outcomes
Khan, A., Schwartz, K. A., Kolts, R. L., Ridgway, D., & Lineberry, C. G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.036 · Cited by 49
Self-citation
Meta-analysis: Fact or fiction? How to interpret meta-analyses
Huf, W., Kalcher, K., Pail, G., Friedrich, M., Peter Filzmoser, A., & Kasper, S. F. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.551544 · Cited by 49
A Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible-Dose Desvenlafaxine Treatment in Outpatients with Major Depressive Disorder
Feiger, A. D., Tourian, K. A., Rosas, G. R., & Padmanabhan, S. K. (2009) · CNS Spectrums · doi:10.1017/s1092852900020046 · Cited by 47
Evaluating the Psychometric Properties of 3 Depression Measures in a Sample of Persons With Traumatic Brain Injury and Major Depressive Disorder
Dyer, J. R., Williams, R. T., Bombardier, C. H., Vannoy, S. D., & Fann, J. R. (2015) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000177 · Cited by 47
Mechanisms of the placebo effect in pain and psychiatric disorders
Holmes, R. D., Tiwari, A. K., & Kennedy, J. L. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.15 · Cited by 49
Smartphone‐based interventions in bipolar disorder: Systematic review and meta‐analyses of efficacy. A position paper from the International Society for Bipolar Disorders ( ISBD ) Big Data Task Force
Anmella, G., Faurholt‐Jepsen, M., Hidalgo‐Mazzei, D., Raduà, J., Passos, I. C., Kapczinski, F. P., Minuzzi, L., Alda, M., Meier, S. M., Hájek, T., et al. (2022) · Bipolar Disorders · doi:10.1111/bdi.13243 · Cited by 55
Can psychological features predict antidepressant response to rTMS? A Discovery–Replication approach
Krepel, N., Rush, A. J., Iseger, T. A., Sack, A. T., & Arns, M. (2019) · Psychological Medicine · doi:10.1017/s0033291718004191 · Cited by 45
A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder
Gommoll, C. P., Greenberg, W. M., & Chen, C. (2014) · Journal of Drug Assessment · doi:10.3109/21556660.2014.884505 · Cited by 43
Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables
Perna, G., Alciati, A., Daccò, S., Grassi, M., & Caldirola, D. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0289 · Cited by 47
Early brain changes associated with psychotherapy in major depressive disorder revealed by resting-state fMRI: Evidence for the top-down regulation theory
Huang, X., Huang, P., Li, D., Zhang, Y., Wang, T., Mu, J., Li, Q., & Xie, P. (2014) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2014.10.011 · Cited by 43
Are studies of psychotherapies for depression more or less generalizable than studies of antidepressants?
Lorenzo‐Luaces, L., Zimmerman, M. A., & Cuijpers, P. J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.066 · Cited by 42
Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety
Goh, K. K., Chen, C.-H., Chiu, Y.-H., & Lu, M.-L. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119844199 · Cited by 44
Making the DSM-5
Paris, J., & Phillips, J. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6504-1 · Cited by 44
Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials
Bradley, A. J., & Lenox‐Smith, A. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113494937 · Cited by 42
Biological Psychiatry: A Practice in Search of a Science
Wyatt, W. J., & Midkiff, D. M. (2006) · Behavior and Social Issues · doi:10.5210/bsi.v15i2.372 · Cited by 41
Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression
Isacsson, G., & Adler, M. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01815.x · Cited by 41
EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial
van der Vinne, N., Vollebregt, M. A., Rush, A. J., Eebes, M., van Putten, M. J. A. M., & Arns, M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.12.005 · Cited by 39
Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression
Shelton, R. C., Andorn, A. C., Mallinckrodt, C. H., Wohlreich, M. M., Raskin, J., Watkin, J. G., & Detke, M. J. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32821c6189 · Cited by 39
Clinical Subtypes of Premenstrual Syndrome and Responses to Sertraline Treatment
Freeman, E. W., Sammel, M. D., Lin, H., Rickels, K., & Sondheimer, S. J. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318236edf2 · Cited by 39
Evidenzbasierte Therapie der Depression
Härter, M. C., Klesse, C., Bermejo, I., Bschor, T., Gensichen, J., Harfst, T., Hautzinger, M., Kolada, C., Kopp, I., Kühner, C., et al. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3084-7 · Cited by 42
Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression
Rudolph, I., Palombo‐Kinne, E., Kirsch, B., Mellinger, U., Breitbarth, H., & Gräser, T. (2004) · Climacteric · doi:10.1080/13697130400001802 · Cited by 39
Empirically supported use of psychiatric medications in adolescents and adults with IBD
Thorkelson, G., Bielefeldt, K., & Szigethy, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000734 · Cited by 39
Structural Models Describing Placebo Treatment Effects in Schizophrenia and Other Neuropsychiatric Disorders
Reddy, V. P., Kozielska, M., Johnson, M. G., Vermeulen, A., de Greef, R., Liu, J., Groothuis, G. M. M., Danhof, M., & Proost, J. H. (2011) · Clinical Pharmacokinetics · doi:10.2165/11590590-000000000-00000 · Cited by 38
Factors associated with initial treatment response with antidepressants in bipolar disorder
Pacchiarotti, I., Valentí, M., Bonnín, C. D. M., Rosa, A. R., Murru, A., Kotzalidis, G. D., Nivoli, A., Sánchez‐Moreno, J., Vieta, E., & Colom, F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.10.002 · Cited by 37
Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy
Santen, G. W. E., Danhof, M., & Pasqua, O. E. D. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.02.001 · Cited by 37
Placebo effect in child and adolescent psychiatric trials.
Parellada, M., Moreno, C., Moreno, M., Espliego, A., de Portugal, E., & Arango, C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.007 · Cited by 43
Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers
Jani, B., McLean, G., Nicholl, B. I., Barry, S., Sattar, N. A., Mair, F. S., & Cavanagh, J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00018 · Cited by 39
Do antidepressants work? A commentary on “Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration” by Kirsch et al
McAllister-Williams, H. (2008) · Evidence-Based Mental Health · doi:10.1136/ebmh.11.3.66 · Cited by 35
A comparison of antidepressant trials using active and inert placebos
Moncrieff, J. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.148 · Cited by 38
Spectroscopic and DFT studies, structural determination, chemical properties and molecular docking of 1-(3-bromo-2-thienyl)-3-[4-(dimethylamino)-phenyl]prop-2-en-1-one
Ramesh, P., Caroline, M. L., Muthu, S., Narayana, B., Raja, M., & Aayisha, S. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.127123 · Cited by 36
S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial
Sarris, J. J., Murphy, J., Stough, C. K. K., Mischoulon, D., Bousman, C., MacDonald, P., Adams, L., Nazareth, S. M., Oliver, G., Cribb, L., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05358-1 · Cited by 36
Declining efficacy in controlled trials of antidepressants: effects of placebo dropout
Schalkwijk, S., Undurraga, J., Tondo, L., & Baldessarini, R. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000224 · Cited by 34
A randomized controlled trial of surf and hike therapy for U.S. active duty service members with major depressive disorder
Walter, K. H., Otis, N. P., Ray, T. N., Glassman, L. H., Beltran, J. L., Kobayashi Elliott, K. T., & Michalewicz-Kragh, B. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04452-7 · Cited by 33
Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5
Cosgrove, L., Krimsky, S., Wheeler, E. E., Kaitz, J. E., Greenspan, S. B., & DiPentima, N. L. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000357499 · Cited by 31
Early Prediction of Fluoxetine Response for Han Chinese Inpatients With Major Depressive Disorder
Lin, C., Lane, H., Chen, C., Juo, S. H., & Yen, C. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318210856f · Cited by 31
Double trouble: Do symptom severity and duration interact to predicting treatment outcomes in adolescent depression?
Lorenzo‐Luaces, L., Rodríguez‐Quintana, N., & Bailey, A. J. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103637 · Cited by 30
The “NICE Guideline” on the treatment of depression
Goldberg, D. P. (2006) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001986 · Cited by 31
Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder
(2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.140203 · Cited by 30
Initial severity and antidepressant efficacy for anxiety disorders, obsessive‐compulsive disorder, and posttraumatic stress disorder: An individual patient data meta‐analysis
de Vries, Y. A., Roest, A. M., Burgerhof, J. G. M., & de Jonge, P. (2018) · Depression and Anxiety · doi:10.1002/da.22737 · Cited by 31
The Borders of Mental Disorder in Psychiatry and the DSM
Pierre, J. M. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000390756.37754.68 · Cited by 31
Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
Abraham, G., Milev, R. V., Lazowski, L., Jokic, R., du Toit, R., & Lowe, A. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a971 · Cited by 30
Is the use of antidepressants associated with patient-reported outcomes following total hip replacement surgery?
Greene, M. E., Rolfson, O., Gordon, M., Annerbrink, K., Malchau, H., & Garellick, G. (2016) · Acta Orthopaedica · doi:10.1080/17453674.2016.1216181 · Cited by 30
Evidenzbasierte Therapie der Depression: Die S3-Leitlinie unipolare Depression
Härter, M. C., Klesse, C., Bermejo, I., Bschor, T., Gensichen, J. S., Harfst, T., Hautzinger, M., Kolada, C., Kopp, I., Kühner, C., et al. (2010) · Der Nervenarzt · Cited by 29
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies
Llorca, P., Lançon, C., Brignone, M., Rive, B., Salah, S., Ereshefsky, L., & François, C. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.969566 · Cited by 31
Placebo Response in Binge Eating Disorder: A Pooled Analysis of 10 Clinical Trials from One Research Group
Blom, T. J., Mingione, C. J., Guerdjikova, A. I., Keck, P. E., Welge, J. A., & McElroy, S. L. (2014) · European Eating Disorders Review · doi:10.1002/erv.2277 · Cited by 31
Predictors of Persistence After a Positive Depression Screen Among Adolescents
Richardson, L. P., McCauley, E., McCarty, C. A., Grossman, D. C., Myaing, M. T., Zhou, C., Richards, J. A., Rockhill, C., & Katon, W. J. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0450 · Cited by 29
Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study
Lisinski, A., Hieronymus, F., Näslund, J., Nilsson, S., & Eriksson, E. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0523-4 · Cited by 29
Depression Screening in Primary Care: Why the Canadian Task Force on Preventive Health Care Did the Right Thing
Thombs, B. D., & Ziegelstein, R. C. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305801207 · Cited by 27
Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressants
Mancini, M., Wade, A. G., Perugi, G., Lenox‐Smith, A., & Schacht, A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.01.001 · Cited by 28
The antidepressant debate and the balanced placebo trial design: An ethical analysis
Waring, D. R. (2008) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2008.09.001 · Cited by 28
The future of selective serotonin reuptake inhibitors (SSRIs) in psychiatric treatment
Taylor, S. J., & Stein, M. B. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.035 · Cited by 27
Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine
Yang, W., Lin, C., Wang, F., & Lu, M.-J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1471-3 · Cited by 28
Should antidepressants be used in minor depression?
Naber, D., & Bullinger, M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/dnaber · Cited by 26
Antidepressants Are Not Overprescribed for Mild Depression
Simon, G. E., Rossom, R. C., Beck, A. L., Waitzfelder, B. E., Coleman, K. J., Stewart, C. C., Operskalski, B. H., Penfold, R. B., & Shortreed, S. M. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09162 · Cited by 27
From Trial and Error to Trial Simulation. Part 2: An Appraisal of Current Beliefs in the Design and Analysis of Clinical Trials for Antidepressant Drugs
Santen, G. W. E., Horrigan, J. P., Danhof, M., & Pasqua, O. E. D. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.107 · Cited by 27
Drug treatment of depression: reflections on the evidence
Anderson, I. M. (2002) · Advances in Psychiatric Treatment · doi:10.1192/apt.9.1.11 · Cited by 27
The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events
Chang, H. S., Won, E., Lee, H.-Y., Ham, B., Kim, Y.-G., & Lee, M.-S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1333-9 · Cited by 25
Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies
Samara, M. T., Goldberg, Y., Levine, S. Z., Furukawa, T. A., Geddes, J. R., Cipriani, A., Davis, J. M., & Leucht, S. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30331-0 · Cited by 26
Twelve-Month Studies on Perilla Oil Intake in Japanese Adults—Possible Supplement for Mental Health
Hashimoto, M., Matsuzaki, K., Kato, S., Hossain, S., Ohno, M., & Shido, O. (2020) · Foods · doi:10.3390/foods9040530 · Cited by 25
Areas of Interest and Social Consideration of Antidepressants on English Tweets: A Natural Language Processing Classification Study
de Anta, L., Álvarez-Mon, M. Á., Álvarez-Mon, M. Á., Salazar, C., Donat‐Vargas, C., Santoma-Vilaclara, J., Martin-Martinez, M., Lahera, G., Gutiérrez-Rojas, L., Rodríguez–Jiménez, R., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020155 · Cited by 26
Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial
van Die, M. D., Bone, K. M., Burger, H., & Teede, H. J. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-41 · Cited by 25
Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?
Evans, K., Sills, T. L., Wunderlich, G. R., & McDonald, H. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.11.006 · Cited by 26
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
Moonen, A. J. H., Wijers, A., Leentjens, A., Christine, C., Factor, S., Juncos, J., Lyness, J., Marsh, L., Panisset, M., Pfeiffer, R., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.025 · Cited by 27
Using classification and regression tree modelling to investigate treatment response to a single low-dose ketamine infusion: Post hoc pooled analyses of randomized placebo-controlled and open-label trials
Chen, M., Wu, H.-J., Li, C., Lin, W.-C., Bai, Y., Tsai, S., Hong, C., Tu, P., Cheng, C., & Su, T. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.045 · Cited by 24
An Examination of 26,168 Hamilton Depression Rating Scale Scores Administered via Interactive Voice Response Across 17 Randomized Clinical Trials
Moore, H. K., Mundt, J. C., Modell, J. G., Rodrigues, H. E., DeBrota, D. J., Jefferson, J. J., & Greist, J. H. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000219918.96434.4d · Cited by 25
Systematic review and meta-analysis of group cognitive behavioural psychotherapy treatment for sub-clinical depression
Krishna, M., Lepping, P., Jones, S., & Lane, S. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.05.043 · Cited by 28
Dosing Strategies for Antidepressant Clinical Trials
Robinson, D. S., & Khan, A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108980.47737.f8 · Cited by 25
Self-citation
Randomized Controlled Trial of the Marriage Checkup: Depression Outcomes
Gray, T. D., Hawrilenko, M., & Cordova, J. V. (2020) · Journal of Marital and Family Therapy · doi:10.1111/jmft.12411 · Cited by 24
Enhancement of Healthy Personality Through Psychiatric Medication: The Influence of SSRIs on Neuroticism and Extraversion
Ilieva, I. P. (2014) · Neuroethics · doi:10.1007/s12152-014-9226-z · Cited by 24
Baseline depression severity as moderator on depression outcomes in psychotherapy and pharmacotherapy
Tröger, A., Miguel, C., Čihařová, M., de Ponti, N., Durman, G., Cuijpers, P. J., & Karyotaki, E. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.047 · Cited by 24
Augmenting serotonin reuptake inhibitors in obsessive–compulsive disorder: What moderates improvement?
Wheaton, M. G., Rosenfield, D., Foa, E. B., & Simpson, H. B. (2015) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000025 · Cited by 27
A systematic review and meta‐analysis of group psychotherapy for sub‐clinical depression in older adults
Krishna, M., Honagodu, A., Rajendra, R., Sundarachar, R., Lane, S., & Lepping, P. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3905 · Cited by 24
Who seeks primary care for sleep, anxiety and depressive disorders from physicians prescribing homeopathic and other complementary medicine? Results from the EPI3 population survey
Grimaldi‐Bensouda, L., Engel, P., Massol, J., Guillemot, D., Avouac, B. P., Duru, G., Lert, F., Magnier, A., Rossignol, M., Rouillon, F., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001498 · Cited by 26
Professional Issues in Pharmacotherapy for Psychologists
McGrath, R., Wiggins, J., Sammons, M. T., Levant, R., Brown, A. B. O., & Stock, W. E. (2004) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.35.2.158 · Cited by 22

Authors: Khan, A., Leventhal, R. M., Khan, S. R., & Brown, W. A.
Affiliations: Northwest Clinical Research Center (US)
Tufts University (US)
Corresponding author: Khan, Arif
Leventhal, Robyn M.
Khan, Shirin R.
ORCID: Khan, Arif
Brown, Walter A.
Venue: Journal of Clinical Psychopharmacology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2002-02
Volume: 22
Issue: 1
Pages: 40-45
ISSN: 0271-0749 (ISSN-L)
DOI: 10.1097/00004714-200202000-00007
OpenAlex: W2094608167
Cited by: 456
References: 21
Citations by year: 2026: 5 · 2025: 7 · 2024: 6 · 2023: 13 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 28 · 2018: 18 · 2017: 21 · 2016: 18 · 2015: 33 · 2014: 41 · 2013: 20 · 2012: 27
FWCI: 10.78
Type: journal article
Language: en
Open access: closed
Locations: Journal of Clinical Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: depression severity, antidepressant response, placebo response, antidepressant clinical trials, trial design, Hamilton Depression Rating Scale, treatment discontinuation, symptom relief
MeSH terms: Adolescent, Adult, Antidepressive Agents, Depressive Disorder, Double-Blind Method, Humans, Personality Inventory, United States, United States Food and Drug Administration, Placebo Effect, Randomized Controlled Trials as Topic, Databases, Factual, Treatment Outcome, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks